These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17053554)

  • 1. Ethnic disparities in the incidence, presentation and complications of malignant hypertension.
    van den Born BJ; Koopmans RP; Groeneveld JO; van Montfrans GA
    J Hypertens; 2006 Nov; 24(11):2299-304. PubMed ID: 17053554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microangiopathic hemolysis and renal failure in malignant hypertension.
    van den Born BJ; Honnebier UP; Koopmans RP; van Montfrans GA
    Hypertension; 2005 Feb; 45(2):246-51. PubMed ID: 15596574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnicity and socio-economic inequalities in malignant hypertension.
    Plouin PF
    J Hypertens; 2006 Nov; 24(11):2161-2. PubMed ID: 17053535
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethnic disparities in malignant hypertension: further observations.
    Karthikeyan VJ; Beevers DG; Lip GY
    J Hypertens; 2007 Apr; 25(4):895; author reply 896. PubMed ID: 17351385
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications and survival of 315 patients with malignant-phase hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hypertens; 1995 Aug; 13(8):915-24. PubMed ID: 8557970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England.
    Lip GY; Beevers M; Beevers G
    J Hypertens; 1994 Nov; 12(11):1297-305. PubMed ID: 7868878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.
    Flack JM; Neaton JD; Daniels B; Esunge P
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):31-40. PubMed ID: 8465834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry.
    Shantsila A; Shantsila E; Beevers DG; Lip GYH
    J Hypertens; 2017 Nov; 35(11):2310-2314. PubMed ID: 28622157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012.
    Gu A; Yue Y; Desai RP; Argulian E
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension.
    James SH; Meyers AM; Milne FJ; Reinach SG
    Nephron; 1995; 71(1):29-34. PubMed ID: 8538845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study.
    Agyemang C; Bindraban N; Mairuhu G; Montfrans Gv; Koopmans R; Stronks K;
    J Hypertens; 2005 Nov; 23(11):1971-7. PubMed ID: 16208137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of renal function in Black South African patients with malignant hypertension: superiority of continuous ambulatory peritoneal dialysis over hemodialysis.
    Katz IJ; Sofianou L; Butler O; Hopley M
    Perit Dial Int; 2001; 21(6):581-6. PubMed ID: 11783767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study.
    Amraoui F; Bos S; Vogt L; van den Born BJ
    BMC Nephrol; 2012 Jul; 13():71. PubMed ID: 22846257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
    Ahmad FS; Cai X; Kunkel K; Ricardo AC; Lash JP; Raj DS; He J; Anderson AH; Budoff MJ; Wright Nunes JA; Roy J; Wright JT; Go AS; St John Sutton MG; Kusek JW; Isakova T; Wolf M; Keane MG;
    Am J Hypertens; 2017 Aug; 30(8):822-829. PubMed ID: 28444108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival of malignant hypertension in blacks, whites and Asians in Britain.
    Clough CG; Beevers DG; Beevers M
    J Hum Hypertens; 1990 Apr; 4(2):94-6. PubMed ID: 2338701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The malignant phase of essential hypertension in Johannesburg Blacks. A prospective study.
    Jhetam D; Dansey R; Morar C; Milne FJ
    S Afr Med J; 1982 Jun; 61(24):899-902. PubMed ID: 7089752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health insurance and racial disparities in pulmonary hypertension outcomes.
    Parikh KS; Stackhouse KA; Hart SA; Bashore TM; Krasuski RA
    Am J Manag Care; 2017 Aug; 23(8):474-480. PubMed ID: 29087147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hypertension and its renal complications in black South Africans.
    Milne FJ; James SH; Veriava Y
    S Afr Med J; 1989 Aug; 76(4):164-7. PubMed ID: 2669174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in hypertension prevalence and contributing determinants - the HELIUS study.
    van Laer SD; Snijder MB; Agyemang C; Peters RJ; van den Born BH
    Eur J Prev Cardiol; 2018 Dec; 25(18):1914-1922. PubMed ID: 30296837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of psychosocial factors in ethnic differences in survival on dialysis in the Netherlands.
    van den Beukel TO; Verduijn M; le Cessie S; Jager KJ; Boeschoten EW; Krediet RT; Siegert CE; Honig A; Dekker FW
    Nephrol Dial Transplant; 2012 Jun; 27(6):2472-9. PubMed ID: 22121230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.